{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:13:57Z","timestamp":1783199637786,"version":"3.54.6"},"posted":{"date-parts":[[2025,7,31]]},"group-title":"In Review","reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,7,3]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Purpose\nType I interferonopathies are Mendelian inborn errors of immunity caused by defective clearance or recognition of nucleic acids, resulting in chronic type I interferon (IFN) activation. DNase II is a lysosomal endonuclease critical for degrading DNA during erythropoiesis and apoptosis. Biallelic loss-of-function variants in\n                  <italic>DNASE2<\/italic>\n                  cause a rare autoinflammatory disorder. We aimed to characterize the clinical, genetic, and functional impact of a novel\n                  <italic>DNASE2<\/italic>\n                  splice site variant in two unrelated patients.\nMethods\nWe performed exome and RNA sequencing to identify and validate variants. A minigene assay assessed splicing effects. DNase II activity was tested in cell lysates. Structural modeling, cytokine profiling, and immune stimulation assays were conducted to evaluate pathway activation and therapeutic response.\nResults\nBoth patients carried a homozygous\n                  <italic>DNASE2<\/italic>\n                  splice site variant (c.511\u2009+\u20095G\u2009&gt;\u2009A), resulting in exon 4 skipping and impaired DNase II activity. They presented at birth with rash, thrombocytopenia, and anemia, later developing neutropenia, arthritis, failure to thrive, and systemic inflammation. One patient also harbored a homozygous\n                  <italic>USP43<\/italic>\n                  variant that reduced USP43 expression and enhanced IFN signaling. Both patients showed increased JAK-STAT activation and responded clinically to JAK1\/2 inhibition with ruxolitinib.\nConclusion\nWe report a novel proximal intronic splice variant in\n                  <italic>DNASE2<\/italic>\n                  associated with DNase II deficiency and type I interferon\u2013mediated autoinflammation. Our findings expand the genotypic and phenotypic spectrum of this disorder, highlight the role of intronic variants in rare immune diseases, and support JAK inhibition as a targeted treatment approach.\n                <\/p>","DOI":"10.21203\/rs.3.rs-7039031\/v1","type":"posted-content","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:14:37Z","timestamp":1754000077000},"source":"Crossref","is-referenced-by-count":1,"title":["Type I interferon-mediated autoinflammation in two unrelated patients due to a proximal intronic splice site variant in DNASE2"],"prefix":"10.21203","author":[{"given":"Oskar","family":"Schnappauf","sequence":"first","affiliation":[{"name":"Bonn-Rhein-Sieg University of Applied Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Wang","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Zhejiang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasily","family":"Burlakov","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical and Research Center for Pediatric Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kozlova","sequence":"additional","affiliation":[{"name":"Ilyinskaya Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B","family":"Beck","sequence":"additional","affiliation":[{"name":"New York University Grossman School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Sampaio","family":"Moura","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie T","family":"Deuitch","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxia Li","family":"Tsai","sequence":"additional","affiliation":[{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gadina","sequence":"additional","affiliation":[{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K","family":"Ombrello","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Zakharova","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical and Research Center for Pediatric Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Kieva","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical and Research Center for Pediatric Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Raikina","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical and Research Center for Pediatric Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ricucci","sequence":"additional","affiliation":[{"name":"Bonn-Rhein-Sieg University of Applied Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Kastner","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shcherbina","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical and Research Center for Pediatric Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Aksentijevich","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-genet-030123-084224","article-title":"How to Build a Fire: The Genetics of Autoinflammatory Diseases","volume":"57","author":"Zhang J","year":"2023","unstructured":"Zhang J, Lee PY, Aksentijevich I, Zhou Q. How to Build a Fire: The Genetics of Autoinflammatory Diseases. Annu Rev Genet. 2023;57:245\u201374. https:\/\/doi.org\/10.1146\/annurev-genet-030123-084224.","journal-title":"Annu Rev Genet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3899\/JRHEUM.2023-1209","article-title":"Autoinflammatory Diseases: A Review","volume":"51","author":"An J","year":"2024","unstructured":"An J, Marwaha A, Laxer RM. Autoinflammatory Diseases: A Review. J Rheumatol. 2024;51:848\u201361. https:\/\/doi.org\/10.3899\/JRHEUM.2023-1209.","journal-title":"J Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/NI.3777","article-title":"The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation","volume":"18","author":"Manthiram K","year":"2017","unstructured":"Manthiram K, Zhou Q, Aksentijevich I, Kastner DL. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol. 2017;18:832\u201342. https:\/\/doi.org\/10.1038\/NI.3777.","journal-title":"Nat Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow YJ","year":"2022","unstructured":"Crow YJ, Stetson DB. The type I interferonopathies: 10 years on. Nat Rev Immunol. 2022;22:471\u201383. https:\/\/doi.org\/10.1038\/s41577-021-00633-9.","journal-title":"Nat Rev Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41467-017-01932-3","article-title":"Type i interferon-mediated autoinflammation due to DNase II deficiency","author":"Rodero MP","year":"2017","unstructured":"Rodero MP, Tesser A, Bartok E, Rice GI, Della Mina E, Depp M, Beitz B, Bondet V, Cagnard N, Duffy D, Dussiot M, Fr\u00e9mond ML, Gattorno M, Guillem F, Kitabayashi N, Porcheray F, Rieux-Laucat F, Seabra L, Uggenti C, Volpi S, Zeef LAH, Alyanakian MA, Beltrand J, Bianco AM, Boddaert N, Brouzes C, Candon S, Caorsi R, Charbit M, Fabre M, Faletra F, Girard M, Harroche A, Hartmann E, Lasne D, Marcuzzi A, Neven B, Nitschke P, Pascreau T, Pastore S, Picard C, Picco P, Piscianz E, Polak M, Quartier P, Rabant M, Stocco G, Taddio A, Uettwiller F, Valencic E, Vozzi D, Hartmann G, Barchet W, Hermine O, Bader-Meunier B, Tommasini A, Crow YJ. Type i interferon-mediated autoinflammation due to DNase II deficiency. Nat Commun. 2017;8. https:\/\/doi.org\/10.1038\/s41467-017-01932-3.","journal-title":"Nat Commun"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/J.CELREP.2014.08.074","article-title":"Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy","volume":"9","author":"Lan YY","year":"2014","unstructured":"Lan YY, Londo\u00f1o D, Bouley R, Rooney MS, Hacohen N. Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy. Cell Rep. 2014;9:180. https:\/\/doi.org\/10.1016\/J.CELREP.2014.08.074.","journal-title":"Cell Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"19386","DOI":"10.1073\/PNAS.1215006109\/-\/DCSUPPLEMENTAL","article-title":"STING manifests self DNA-dependent inflammatory disease","volume":"109","author":"Ahn J","year":"2012","unstructured":"Ahn J, Gutman D, Saijo S, Barber GN. STING manifests self DNA-dependent inflammatory disease. Proc Natl Acad Sci U S A. 2012;109:19386\u201391. https:\/\/doi.org\/10.1073\/PNAS.1215006109\/-\/DCSUPPLEMENTAL.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.10.602775","author":"Hao K","year":"2024","unstructured":"Hao K, Gao KM, Strauss M, Subramanian S, Marshak-Rothstein A. IFN\u03b3 initiates TLR9-dependent autoimmune hepatitis in DNase II deficient mice. BioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.07.10.602775"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"109593","DOI":"10.1016\/j.clim.2023.109593","article-title":"First reported use of anifrolumab to treat a monogenic interferonopathy (DNASE2 loss of function)","volume":"250","author":"Doroudchi A","year":"2023","unstructured":"Doroudchi A, Butte M. First reported use of anifrolumab to treat a monogenic interferonopathy (DNASE2 loss of function). Clin Immunol. 2023;250:109593. https:\/\/doi.org\/10.1016\/j.clim.2023.109593.","journal-title":"Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jaci.2019.11.020","article-title":"Janus kinase inhibition for autoinflammation in patients with DNASE2 deficiency","volume":"145","author":"Hong Y","year":"2020","unstructured":"Hong Y, Capitani M, Murphy C, Pandey S, Cavounidis A, Takeshita H, Nanthapisal S, Yasuda T, Bader-Meunier B, McCreary D, Omoyinmi E, Rao A, Booth C, Gilmour K, Sebire N, Shah N, Klein N, Bullock AN, Eleftheriou D, Uhlig HH, Brogan P. Janus kinase inhibition for autoinflammation in patients with DNASE2 deficiency. J Allergy Clin Immunol. 2020;145:701\u2013e7058. https:\/\/doi.org\/10.1016\/j.jaci.2019.11.020.","journal-title":"J Allergy Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1111\/1756-185X.14826","article-title":"A young boy with rash, arthritis, and developmental delay: Monogenic lupus due to DNASE2 gene defect","volume":"26","author":"Basu S","year":"2023","unstructured":"Basu S, Sil A, Jindal AK, Tyagi R, Arafath MY, Vyas S, Rawat A. A young boy with rash, arthritis, and developmental delay: Monogenic lupus due to DNASE2 gene defect. Int J Rheum Dis. 2023;26:2599\u2013602. https:\/\/doi.org\/10.1111\/1756-185X.14826.","journal-title":"Int J Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1042\/BCJ20210735","article-title":"Deubiquitinases in cell death and inflammation","volume":"479","author":"Newton K","year":"2022","unstructured":"Newton K, Gitlin AD. Deubiquitinases in cell death and inflammation. Biochem J. 2022;479:1103. https:\/\/doi.org\/10.1042\/BCJ20210735.","journal-title":"Biochem J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41584-022-00778-4","article-title":"Disorders of ubiquitylation: unchained inflammation","volume":"18","author":"Beck DB","year":"2022","unstructured":"Beck DB, Werner A, Kastner DL, Aksentijevich I. Disorders of ubiquitylation: unchained inflammation. Nat Rev Rheumatol. 2022;18:435\u201347. https:\/\/doi.org\/10.1038\/s41584-022-00778-4.","journal-title":"Nat Rev Rheumatol"},{"issue":"1 2015","key":"ref14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou Q","year":"2015","unstructured":"Zhou Q, Wang H, Schwartz DM, Stoffels M, Hwan Park Y, Zhang Y, Yang D, Demirkaya E, Takeuchi M, Tsai WL, Lyons JJ, Yu X, Ouyang C, Chen C, Chin DT, Zaal K, Chandrasekharappa SC, Hanson EP, Yu Z, Mullikin JC, Hasni SA, Wertz IE, Ombrello AK, Stone DL, Hoffmann P, Jones A, Barham BK, Leavis HL, Van Royen-Kerkof A, Sibley C, Batu ED, G\u00fcl A, Siegel RM, Boehm M, Milner JD, Ozen S, Gadina M, Chae JJ, Laxer RM, Kastner DL, Aksentijevich I. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2015;48(1 2015):48:67\u201373. https:\/\/doi.org\/10.1038\/ng.3459.","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1084\/JEM.20231941\/276707","article-title":"A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome","author":"Takeda Y","year":"2024","unstructured":"Takeda Y, Ueki M, Matsuhiro J, Walinda E, Tanaka T, Yamada M, Fujita H, Takezaki S, Kobayashi I, Tamaki S, Nagata S, Miyake N, Matsumoto N, Osawa M, Yasumi T, Heike T, Ohtake F, Saito MK, Toguchida J, Takita J, Ariga T, Iwai K. A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome. J Exp Med. 2024;221. https:\/\/doi.org\/10.1084\/JEM.20231941\/276707.","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"10127","DOI":"10.1073\/PNAS.1612594113\/SUPPL_FILE\/PNAS.201612594SI.PDF","article-title":"Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease","volume":"113","author":"Zhou Q","year":"2016","unstructured":"Zhou Q, Yu X, Demirkaya E, Deuitch N, Stone D, Tsai WL, Kuehn HS, Wang H, Yang D, Park YH, Ombrello AK, Blake M, Romeo T, Remmers EF, Chae JJ, Mullikin JC, G\u00fczel F, Milner JD, Boehm M, Rosenzweig SD, Gadina M, Welch SB, \u00d6zen S, Topaloglu R, Abinun M, Kastner DL, Aksentijevich I. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc Natl Acad Sci U S A. 2016;113:10127\u201332. https:\/\/doi.org\/10.1073\/PNAS.1612594113\/SUPPL_FILE\/PNAS.201612594SI.PDF.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2016.07.019","article-title":"The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity","volume":"166","author":"Damgaard RB","year":"2016","unstructured":"Damgaard RB, Walker JA, Marco-Casanova P, Morgan NV, Titheradge HL, Elliott PR, McHale D, Maher ER, McKenzie ANJ, Komander D. The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity. Cell. 2016;166:1215\u2013e123020. https:\/\/doi.org\/10.1016\/j.cell.2016.07.019.","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3950863\/v2","article-title":"OTULIN-related conditions: Report of a new case and review of the literature using GenIA","author":"Caballero-Oteyza A","year":"2024","unstructured":"Caballero-Oteyza A, Crisponi L, Peng XP, Wang H, Mrovecova P, Olla S, Siguri C, Marnissi F, Jouhadi Z, Aksentijevich I, Grimbacher B, Proietti M. OTULIN-related conditions: Report of a new case and review of the literature using GenIA. Res Sq. 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-3950863\/v2.","journal-title":"Res Sq"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1038\/S44318-024-00166-6\/","article-title":"Deubiquitinating enzyme mutagenesis screens identify a USP43-dependent HIF-1 transcriptional response","volume":"43","author":"Pauzaite T","year":"2024","unstructured":"Pauzaite T, Wit N, Seear RV, Nathan JA. Deubiquitinating enzyme mutagenesis screens identify a USP43-dependent HIF-1 transcriptional response. EMBO J. 2024;43:3677\u2013709. https:\/\/doi.org\/10.1038\/S44318-024-00166-6\/. SUPPL_FILE\/44318_2024_166_MOESM13_ESM.PDF.","journal-title":"EMBO J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1073\/PNAS.1120542109\/-\/DCSUPPLEMENTAL","article-title":"Genome-wide siRNA screen for mediators of NF-\u03baB activation","volume":"109","author":"Gewurz BE","year":"2012","unstructured":"Gewurz BE, Towfic F, Mar JC, Shinners NP, Takasaki K, Zhao B, Cahir-McFarland ED, Quackenbush J, Xavier RJ, Kieff E. Genome-wide siRNA screen for mediators of NF-\u03baB activation. Proc Natl Acad Sci U S A. 2012;109:2467\u201372. https:\/\/doi.org\/10.1073\/PNAS.1120542109\/-\/DCSUPPLEMENTAL.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1101\/201178","article-title":"Scaling accurate genetic variant discovery to tens of thousands of samples 2017","author":"Poplin R","unstructured":"Poplin R, Ruano-Rubio V, DePristo MA, Fennell TJ, Carneiro MO, Van der Auwera GA, Kling DE, Gauthier LD, Levy-Moonshine A, Roazen D, Shakir K, Thibault J, Chandran S, Whelan C, Lek M, Gabriel S, Daly MJ, Neale B, MacArthur DG, Banks E. Scaling accurate genetic variant discovery to tens of thousands of samples 2017. https:\/\/doi.org\/10.1101\/201178"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e1003153","DOI":"10.1371\/journal.pcbi.1003153","article-title":"GEMINI: Integrative Exploration of Genetic Variation and Genome Annotations","volume":"9","author":"Paila U","year":"2013","unstructured":"Paila U, Chapman BA, Kirchner R, Quinlan AR. GEMINI: Integrative Exploration of Genetic Variation and Genome Annotations. PLoS Comput Biol. 2013;9:e1003153. https:\/\/doi.org\/10.1371\/journal.pcbi.1003153.","journal-title":"PLoS Comput Biol"},{"key":"ref23","doi-asserted-by":"publisher","author":"Pedersen BS","unstructured":"Pedersen BS, Brown JM, Dashnow H, Wallace AD, Velinder M, Tristani-Firouzi M, Schiffman JD, Tvrdik T, Mao R, Hunter Best D, Bayrak-Toydemir P, Quinlan AR. Effective variant filtering and expected candidate variant yield in studies of rare human disease n.d. https:\/\/doi.org\/10.1038\/s41525-021-00227-3","DOI":"10.1038\/s41525-021-00227-3"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/ANNUREV-PATHOL-020117-043952\/CITE\/REFWORKS","article-title":"Type i Interferons in Autoimmune Disease","volume":"14","author":"Crow MK","year":"2019","unstructured":"Crow MK, Olferiev M, Kirou KA. Type i Interferons in Autoimmune Disease. Annu Rev Pathol. 2019;14:369\u201393. https:\/\/doi.org\/10.1146\/ANNUREV-PATHOL-020117-043952\/CITE\/REFWORKS.","journal-title":"Annu Rev Pathol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41591-023-02401-9","article-title":"Integrated multi-omics for rapid rare disease diagnosis on a national scale","volume":"29","author":"Lunke S","year":"2023","unstructured":"Lunke S, Bouffler SE, Patel CV, Sandaradura SA, Wilson M, Pinner J, Hunter MF, Barnett CP, Wallis M, Kamien B, Tan TY, Freckmann ML, Chong B, Phelan D, Francis D, Kassahn KS, Ha T, Gao S, Arts P, Jackson MR, Scott HS, Eggers S, Rowley S, Boggs K, Rakonjac A, Brett GR, de Silva MG, Springer A, Ward M, Stallard K, Simons C, Conway T, Halman A, Van Bergen NJ, Sikora T, Semcesen LN, Stroud DA, Compton AG, Thorburn DR, Bell KM, Sadedin S, North KN, Christodoulou J, Stark Z. Integrated multi-omics for rapid rare disease diagnosis on a national scale. Nat Med 2023. 2023;29:7. https:\/\/doi.org\/10.1038\/s41591-023-02401-9.","journal-title":"Nat Med 2023"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/S13073-022-01087-X","article-title":"A systematic analysis of splicing variants identifies new diagnoses in the 100,000 Genomes Project","author":"Blakes AJM","year":"2022","unstructured":"Blakes AJM, Wai HA, Davies I, Moledina HE, Ruiz A, Thomas T, Bunyan D, Thomas NS, Burren CP, Greenhalgh L, Lees M, Pichini A, Smithson SF, Taylor Tavares AL, O\u2019Donovan P, Douglas AGL, Whiffin N, Baralle D, Lord J. A systematic analysis of splicing variants identifies new diagnoses in the 100,000 Genomes Project. Genome Med. 2022;14. https:\/\/doi.org\/10.1186\/S13073-022-01087-X.","journal-title":"Genome Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/J.CELL.2018.12.015","article-title":"Predicting Splicing from Primary Sequence with Deep Learning","volume":"176","author":"Jaganathan K","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, Kosmicki JA, Arbelaez J, Cui W, Schwartz GB, Chow ED, Kanterakis E, Gao H, Kia A, Batzoglou S, Sanders SJ, Farh KKH. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019;176:535\u2013e54824. https:\/\/doi.org\/10.1016\/J.CELL.2018.12.015.","journal-title":"Cell"},{"issue":"1 2024","key":"ref28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-53088-6","article-title":"SpliceTransformer predicts tissue-specific splicing linked to human diseases","volume":"15","author":"You N","unstructured":"You N, Liu C, Gu Y, Wang R, Jia H, Zhang T, Jiang S, Shi J, Chen M, Guan MX, Sun S, Pei S, Liu Z, Shen N. SpliceTransformer predicts tissue-specific splicing linked to human diseases. Nat Commun 2024 15:1 2024;15:1\u201318. https:\/\/doi.org\/10.1038\/s41467-024-53088-6","journal-title":"Nat Commun 2024"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum MJ","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980\u20135. https:\/\/doi.org\/10.1093\/nar\/gkt1113.","journal-title":"Nucleic Acids Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/GIM.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405. https:\/\/doi.org\/10.1038\/GIM.2015.30.","journal-title":"Genet Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1042\/bj20021875","article-title":"Structural requirements of human DNase IIalpha for formation of the active enzyme: the role of the signal peptide, N-glycosylation, and disulphide bridging","volume":"371","author":"MacLEA KS","year":"2003","unstructured":"MacLEA KS, KRIESER RJ. Structural requirements of human DNase IIalpha for formation of the active enzyme: the role of the signal peptide, N-glycosylation, and disulphide bridging. Biochem J. 2003;371:867\u201376. https:\/\/doi.org\/10.1042\/bj20021875.","journal-title":"Biochem J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen S","year":"2024","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, Alf\u00f6ldi J, Watts NA, Vittal C, Gauthier LD, Poterba T, Wilson MW, Tarasova Y, Phu W, Grant R, Yohannes MT, Koenig Z, Farjoun Y, Banks E, Donnelly S, Gabriel S, Gupta N, Ferriera S, Tolonen C, Novod S, Bergelson L, Roazen D, Ruano-Rubio V, Covarrubias M, Llanwarne C, Petrillo N, Wade G, Jeandet T, Munshi R, Tibbetts K, Donnell-Luria A, Solomonson M, Seed C, Martin AR, Talkowski ME, Rehm HL, Daly MJ, Tiao G, Neale BM, MacArthur DG, Karczewski KJ. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625:92\u2013100. https:\/\/doi.org\/10.1038\/s41586-023-06045-0. Genome Aggregation Database Consortium, O\u2019.","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen S","year":"2024","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, Alf\u00f6ldi J, Watts NA, Vittal C, Gauthier LD, Poterba T, Wilson MW, Tarasova Y, Phu W, Grant R, Yohannes MT, Koenig Z, Farjoun Y, Banks E, Donnelly S, Gabriel S, Gupta N, Ferriera S, Tolonen C, Novod S, Bergelson L, Roazen D, Ruano-Rubio V, Covarrubias M, Llanwarne C, Petrillo N, Wade G, Jeandet T, Munshi R, Tibbetts K, Donnell-Luria A, Solomonson M, Seed C, Martin AR, Talkowski ME, Rehm HL, Daly MJ, Tiao G, Neale BM, MacArthur DG, Karczewski KJ. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625:92\u2013100. https:\/\/doi.org\/10.1038\/s41586-023-06045-0. Genome Aggregation Database Consortium, O\u2019.","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41525-021-00203-x","article-title":"The prevalence, genetic complexity and population-specific founder effects of human autosomal recessive disorders","volume":"6","author":"Xiao Q","year":"2021","unstructured":"Xiao Q, Lauschke VM. The prevalence, genetic complexity and population-specific founder effects of human autosomal recessive disorders. NPJ Genom Med. 2021;6:41. https:\/\/doi.org\/10.1038\/s41525-021-00203-x.","journal-title":"NPJ Genom Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4311388","author":"Zhao Z","year":"2023","unstructured":"Zhao Z, Lin Z, Guo X, Al-Danakh A, He H, Qin H, Ma C, Zhang N, Tan G. Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells. J Immunol Res. 2023;2023. https:\/\/doi.org\/10.1155\/2023\/4311388"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"152055","DOI":"10.1016\/J.SEMARTHRIT.2022.152055","article-title":"Autoinflammatory syndromes with coexisting variants in Mediterranean Fever and other genes: Utility of multiple gene screening and the possible impact of gene dosage","volume":"56","author":"Karamanakos A","year":"2022","unstructured":"Karamanakos A, Tektonidou M, Vougiouka O, Gerodimos C, Katsiari C, Pikazis D, Settas L, Tsitsami E, Speletas M, Sfikakis P, Germenis A, Laskari K. Autoinflammatory syndromes with coexisting variants in Mediterranean Fever and other genes: Utility of multiple gene screening and the possible impact of gene dosage. Semin Arthritis Rheum. 2022;56:152055. https:\/\/doi.org\/10.1016\/J.SEMARTHRIT.2022.152055.","journal-title":"Semin Arthritis Rheum"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/08916934.2019.1613382","article-title":"Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine","volume":"52","author":"Yao Q","year":"2019","unstructured":"Yao Q, Li E, Shen B. Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine. Autoimmunity. 2019;52:48\u201356. https:\/\/doi.org\/10.1080\/08916934.2019.1613382.","journal-title":"Autoimmunity"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/FIMMU.2023.1265404","article-title":"Implications of combined NOD2 and other gene mutations in autoinflammatory diseases","author":"Nomani H","year":"2023","unstructured":"Nomani H, Deng Z, Navetta-Modrov B, Yang J, Yun M, Aroniadis O, Gorevic P, Aksentijevich I, Yao Q. Implications of combined NOD2 and other gene mutations in autoinflammatory diseases. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/FIMMU.2023.1265404.","journal-title":"Front Immunol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1126\/science.aao1729","article-title":"Systematic analysis of complex genetic interactions","author":"Kuzmin E","year":"2018","unstructured":"Kuzmin E, VanderSluis B, Wang W, Tan G, Deshpande R, Chen Y, Usaj M, Balint A, Mattiazzi Usaj M, van Leeuwen J, Koch EN, Pons C, Dagilis AJ, Pryszlak M, Wang ZY, Hanchard J, Riggi M, Xu K, Heydari H, San Luis B-J, Shuteriqi E, Zhu H, Van Dyk N, Sharifpoor S, Costanzo M, Loewith R, Caudy A, Bolnick D, Brown GW, Andrews BJ, Boone C, Myers CL. Systematic analysis of complex genetic interactions. Science. 2018;360. https:\/\/doi.org\/10.1126\/science.aao1729.","journal-title":"Science"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cell.2019.02.040","article-title":"A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers","volume":"177","author":"Boycott KM","year":"2019","unstructured":"Boycott KM, Hartley T, Biesecker LG, Gibbs RA, Innes AM, Riess O, Belmont J, Dunwoodie SL, Jojic N, Lassmann T, Mackay D, Temple IK, Visel A, Baynam G. A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers. Cell. 2019;177:32\u20137. https:\/\/doi.org\/10.1016\/j.cell.2019.02.040.","journal-title":"Cell"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Kawane K, Tanaka H, Kitahara Y, \u2026 SS-P of the, 2010 undefined. Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation.PnasOrgK Kawane, H Tanaka, Y Kitahara, S Shimaoka, S NagataProceedings of the National Academy of Sciences, 2010\u2022pnasOrg 2010;107:19432\u20137. https:\/\/doi.org\/10.1073\/pnas.1010603107.","DOI":"10.1073\/pnas.1010603107"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/CR.2016.40","article-title":"Ubiquitin signaling in immune responses","volume":"26","author":"Hu H","year":"2016","unstructured":"Hu H, Sun SC. Ubiquitin signaling in immune responses. Cell Res. 2016;26:457. https:\/\/doi.org\/10.1038\/CR.2016.40.","journal-title":"Cell Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 biology into effective treatments","volume":"16","author":"Choy EH","year":"2020","unstructured":"Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T. Translating IL-6 biology into effective treatments. Nat Rev Rheumatol. 2020;16:335\u201345. https:\/\/doi.org\/10.1038\/s41584-020-0419-z.","journal-title":"Nat Rev Rheumatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jaci.2021.07.028","article-title":"JAK inhibition in the type I interferonopathies","volume":"148","author":"Crow YJ","year":"2021","unstructured":"Crow YJ, Neven B, Fr\u00e9mond ML. JAK inhibition in the type I interferonopathies. J Allergy Clin Immunol. 2021;148:991\u20133. https:\/\/doi.org\/10.1016\/j.jaci.2021.07.028.","journal-title":"J Allergy Clin Immunol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7039031\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7039031\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:25:13Z","timestamp":1767705913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7039031\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":44,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7039031\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,7,31]]},"subtype":"preprint"}}